Jefferies Group LLC Nevro Corp Call Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Sep 21, 2023	SELL	$59.95 - $92.06 $2.1 Million - $3.22 Million	-35,000 Reduced 84.95%	6,200 $448,000
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $2.1 Million - $3.22 Million	-35,000 Reduced 84.95%	6,200 $448,000
Q4 2021 Sep 21, 2023	BUY	$81.07 - $121.29 $2.45 Million - $3.66 Million	30,200 Added 274.55%	41,200 $3.34 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $2.45 Million - $3.66 Million	30,200 Added 274.55%	41,200 $3.34 Million
Q1 2021 Sep 21, 2023	BUY	$132.81 - $182.18 $1.46 Million - $2 Million	11,000 New	11,000 $1.53 Million
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $1.46 Million - $2 Million	11,000 New	11,000 $1.54 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $2.28 Million - $3.04 Million	-16,500 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $7.82 Million - $9.97 Million	-68,500 Reduced 80.59%	16,500 $2.3 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $6.71 Million - $9.74 Million	75,000 Added 750.0%	85,000 $10.2 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $355,200 - $626,200	10,000 New	10,000 $625,000

150

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.